PMV Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	78	159	397	1,048	2,754
Market Cap Growth	-59.95%	-60.08%	-62.10%	-61.94%	-
Enterprise Value	-105	-32	169	761	2,393
PE Ratio	-	-2.30	-5.42	-18.12	-79.97
PB Ratio	0.38	0.70	1.62	3.40	7.67
P/FCF Ratio	-1.50	-2.80	-5.54	-21.88	-83.74
P/OCF Ratio	-1.54	-2.85	-6.23	-22.51	-84.12
EV/EBITDA Ratio	1.54	0.47	-2.33	-13.47	-70.13
EV/EBIT Ratio	1.51	0.46	-2.31	-13.17	-69.48
EV/FCF Ratio	1.69	0.57	-2.36	-15.89	-72.75
Debt / Equity Ratio	0.06	0.06	0.06	0.04	-
Debt / EBITDA Ratio	-0.20	-0.20	-0.19	-0.20	-
Debt / FCF Ratio	-0.22	-0.23	-0.19	-0.23	-
Quick Ratio	16.48	14.53	22.33	24.39	56.38
Current Ratio	16.79	14.78	22.80	24.66	56.91
Return on Equity (ROE)	-29.10%	-30.30%	-27.30%	-17.50%	-23.90%
Return on Assets (ROA)	-26.20%	-27.30%	-25.00%	-16.70%	-14.70%
Return on Capital (ROIC)	-34.06%	-33.53%	-29.63%	-18.23%	-9.73%
Earnings Yield	-81.12%	-43.48%	-18.45%	-5.52%	-1.25%
FCF Yield	-72.56%	-35.70%	-18.06%	-4.57%	-1.19%
Buyback Yield / Dilution	-12.39%	-5.31%	-1.01%	-214.23%	-373.26%
Total Shareholder Return	-12.39%	-5.31%	-1.01%	-214.23%	-373.26%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).